Real-time enrollment status for this diffuse midline glioma (dmg) clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:28 PM UTC
| NCT Number | NCT04732065 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Midline Glioma (DMG) |
| Phase | PHASE1 |
| Target Enrollment | 208 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Sabine Mueller, MD, PhD |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of July 17, 2026: Clinical trial NCT04732065 is currently recruiting participants. This phase1 study for diffuse midline glioma (dmg) is actively seeking new participants at 5 locations across the United States. The study is sponsored by Sabine Mueller, MD, PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04732065 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04732065 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.